Search
for
Sort by
Research 61–90 of 1000+
- 12 Treatment of hirsutism with 5α-reductase inhibitors
- Is there a role for 5α‐reductase inhibitors in transgender individuals?
- Re: Risk of Erectile Dysfunction Associated with Use of 5α-Reductase Inhibitors for Benign Prostatic Hyperplasia or Alopecia: Population Based Studies Using the Clinical Practice Research Datalink
- Safety of 5α-reductase inhibitors and spironolactone in breast cancer patients receiving endocrine therapies
- Persistent Erectile Dysfunction after Discontinuation of 5-Alpha Reductase Inhibitor Therapy in Rats Depending on the Duration of Treatment
- Post-Finasteride Syndrome: An Induced Delusional Disorder with the Potential of a Mass Psychogenic Illness?
- Side Effects of 5‐Alpha Reductase Inhibitors: A Comprehensive Review
- Do 5α-Reductase Inhibitors Raise Circulating Serum Testosterone Levels? A Comprehensive Review and Meta-Analysis to Explaining Paradoxical Results
- The Dark Side of 5α-Reductase Inhibitors' Therapy: Sexual Dysfunction, High Gleason Grade Prostate Cancer and Depression
- Steroidal 5α-reductase and 17α-hydroxylase/17,20-lyase (CYP17) inhibitors useful in the treatment of prostatic diseases
- Effects of pre- and post-pubertal dihydrotestosterone treatment on penile length in 5α-reductase type 2 deficiency
- 5-Alpha reductase deficiency
- 5α-Metabolism in Finasteride-Treated Subjects and Male Pseudohermaphrodites with Inherited 5α-Reductase Deficiency
- Physiopathological role of the enzymatic complex 5α-reductase and 3α/β-hydroxysteroid oxidoreductase in the generation of progesterone and testosterone neuroactive metabolites
- Isoallopregnanolone reduces tic‐like behaviours in the D1 CT ‐7 mouse model of Tourette syndrome
- Clinical relevance of testosterone and dihydrotestosterone metabolism in women
- Targeting neurosteroid synthesis as a therapy for schizophrenia-related alterations induced by early psychosocial stress
- Androgens and hair: a biological paradox
- Pharmacological Approaches in Managing Symptomatic Relief of Benign Prostatic Hyperplasia: A Comprehensive Review
- FINASTERIDE IN MODERN MEDICINE: THERAPEUTIC APPLICATIONS AND SYSTEMIC HEALTH IMPLICATIONS
- Epidemiology and treatment modalities for the management of benign prostatic hyperplasia
- Androgen Deprivation Therapy in Prostate Cancer: Focusing on Sexual Side Effects
- Chapter 23. Therapeutic Control of Androgen Action
- Clinicopathological characteristics and treatment outcomes of fibrosing alopecia in a pattern distribution: A retrospective cohort study
- Non-surgical management of BPH: An updated review of current literature and state of the art on natural compounds and medical therapy
- Use of genetics in the prediction of success in male pattern hair loss therapy and mechanistic studies
- Drug-induced male infertility: a real-world study using FAERS and EudraVigilance databases
- A randomized phase II trial on the addition of dutasteride to combined androgen blockade therapy versus combined androgen blockade therapy alone in patients with advanced or metastatic salivary duct carcinoma – the DUCT study protocol
- The role of dutasteride in the treatment of benign prostatic obstruction and related conditions
- Finasteride and androgenic alopecia; from therapeutic options to medical implications